Cargando…
Nr4a transcription factors limit CAR T cell function in solid tumors
T cells expressing chimeric antigen receptors (CAR) targeting human CD19 (huCD19) have exhibited impressive clinical efficacy against B cell malignancies(1,2). CAR-T cells have been less effective against solid tumors(3–5), in part because they enter a hyporesponsive (“exhausted” or “dysfunctional”)...
Autores principales: | Chen, Joyce, López-Moyado, Isaac F., Seo, Hyungseok, Lio, Chan-Wang J., Hempleman, Laura J., Sekiya, Takashi, Yoshimura, Akihiko, Scott-Browne, James P., Rao, Anjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546093/ https://www.ncbi.nlm.nih.gov/pubmed/30814732 http://dx.doi.org/10.1038/s41586-019-0985-x |
Ejemplares similares
-
Regulation of peripheral Th/Treg differentiation and suppression of airway inflammation by Nr4a transcription factors
por: Sekiya, Takashi, et al.
Publicado: (2021) -
BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
por: Seo, Hyungseok, et al.
Publicado: (2021) -
Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells
por: Sekiya, Takashi, et al.
Publicado: (2015) -
Comparison Between Nr4a Transcription Factor Regulation and Function in Lymphoid and Tumor Treg Cells
por: Sekiya, Takashi
Publicado: (2022) -
Inducible disruption of Tet genes results in myeloid malignancy, readthrough transcription, and a heterochromatin-to-euchromatin switch
por: Yuita, Hiroshi, et al.
Publicado: (2023)